The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
32
No.
28
July 21, 2006
- FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.
- FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.”
- NCI Says Sponsored Meetings Must Be Held In Smoke-Free Localities As of Jan. 1.
- ACS Presents Awards To Anti-Tobacco Activists.
TCL
Vol.
32
No.
29
July 28, 2006
- ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.
- Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.
- Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.
- Bush Appoints Seven to NCAB, Designates Runowicz as Chairman.
- IOM Report Recommends Solutions to Problem of Medication Errors.
- Jury Finds USC Geneticist William French Anderson Guilty of Sexual Abuse of a Child.
CCL
Vol.
29
No.
7
July 28, 2006
- ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer
- Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds
- Lapatinib Improves Outcome Of Advanced Breast Cancer
- GSK Vaccine Prevents Lesions Associated With HPV
- ASCO Releases Guideline On Larynx Preservation
- Chest X-Rays In BRCA Carriers May Increase Cancer Risk
- Female Smokers Face Double Risk For Lung Cancer
- NCI-Approved Clinical Trials
TCL
Vol.
32
No.
30
August 04, 2006
- Von Eschenbach’s Proposal for Plan B Fails to Impress Democrats, Angers Social Conservatives.
- Carmona’s Term as Surgeon General Expires.
- Tri-Institutional Stem Cell Initiative Funds Grants.
- NCI Budget Chief John Hartinger Retires.
- FDA Employee Inspired to Compose an Anthem for the Agency.
- ASCO Breaks Ground For New HQ.
CCL
Vol.
29
No.
8
August 25, 2006
- Heart Function Of Breast Cancer Patients Should Be Monitored, Two Studies Find
- Finasteride Improved Performance Of PSA In Prostate Cancer Prevention Trial
- Adverse Events Of Chemo More Common Than Expected
- BRCA Mutations In About 2% Of Breast Cancer Patients
- Cedars-Sinai Develops Criteria For FDG-PET In Breast Cancer
- Genetic Risk Factor Implicated In Prostate Cancer In Blacks
- ASCO, NCCN Develop Quality Measures For Cancer Care
- Mayo Clinic Develops New Jaw Reconstruction Method
- One In 8 Survivors Report Suicidal Thoughts, Attempts
- NCI-Approved Clinical Trials
TCL
Vol.
32
No.
32
September 15, 2006
- FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.
- Cancer Center Directors Say Collaboration, Funding, and Application of Best Practices Will Reduce the Burden of Cancer.
- Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.
